￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Imvarumab/carboplatin/etoposide proven tolerable in ES-SCLC

2026-02-01 22:25:32

Check Details
How much can zolbetuximab be reimbursed after it is included in medical insurance?

2026-02-01 22:25:32

Check Details
Does treatment with Mitotane require continuous medication?

2026-02-01 22:25:32

Check Details
Analysis of the differences between Erlotinib and Tarceva

2026-02-01 22:25:32

Check Details
Can't I stop taking Tofacitinib/Shangjie once I take it?

2026-02-01 22:25:32

Check Details
What are the possible adverse reactions of cycloserine?

2026-02-01 22:25:32

Check Details
The price difference between the original drug and generic drug of Linezolid/Siwo

2026-02-01 22:25:32

Check Details
What are the adverse reactions of Riboxil/Calilon?

2026-02-01 22:25:32

Check Details
Indications and scope of use of Cemiplimab

2026-02-01 22:25:32

Check Details
Comparison of the therapeutic effects of daprodustat and ESA

2026-02-01 22:25:32

Check Details
The relationship between durvalumab and Infinifer

2026-02-01 22:25:32

Check Details
Does zotuximab/veluoyin belong to the category of chemotherapy drugs?

2026-02-01 22:25:32

Check Details
Category
相关知识